Kilitch Drugs (India) Investor Sentiment

KILITCH Stock   312.55  5.35  1.68%   
Under 62% of Kilitch Drugs' investor base is looking to short. The analysis of overall sentiment of trading Kilitch Drugs Limited stock suggests that many investors are alarmed at this time. Kilitch Drugs' investing sentiment shows overall attitude of investors towards Kilitch Drugs Limited.
  
over six months ago at news.google.com         
Krebs Biochemicals Industries Ltd leads gainers in B group - Business Standard
Google News at Macroaxis
over six months ago at news.google.com         
Kwality Pharmaceuticals Ltd Share Price Today Kwality Pharmaceuticals Ltd Stock Price Live NSEBSE, K...
Google News at Macroaxis
over six months ago at news.google.com         
Kilitch Drugs Standalone March 2024 Net Sales at Rs .14 crore, down 9.58 percent Y-o-Y - Moneycontro...
Google News at Macroaxis
over six months ago at news.google.com         
Kilitch Drugs consolidated net profit rises 0.84 percent in the March 2024 quarter - Business Standa...
Google News at Macroaxis
over six months ago at news.google.com         
Results Calendar For May 27 NSE, BSE companies announcing Q4 FY 2024 earnings on Monday - FULL list ...
Google News at Macroaxis
over six months ago at news.google.com         
The FDA serves up warning letters to pair of Indian pharmas - FiercePharma
Google News at Macroaxis
over six months ago at news.google.com         
Kilitch Drugs Ltd Share Price Today Kilitch Drugs Ltd Stock Price Live NSEBSE, Kilitch Drugs Ltd ......
Google News at Macroaxis
over six months ago at news.google.com         
We Think Indus Towers Can Stay On Top Of Its Debt - Simply Wall St
Google News at Macroaxis
over six months ago at news.google.com         
Heres Why Kilitch Drugs Can Manage Its Debt Responsibly - Simply Wall St
Google News at Macroaxis
over six months ago at news.google.com         
Heres Why Kilitch Drugs Can Manage Its Debt Responsibly - Simply Wall St
Google News at Macroaxis
over six months ago at news.google.com         
Eye products sold at Walmart, CVS could pose infection risk - New York Post
Google News at Macroaxis
over a year ago at news.google.com         
Kilitch Drugs Limiteds Subsidiary Won Tender Issued by the Ethiopian Pharmaceutical Supply Service o...
Google News at Macroaxis
over a year ago at news.google.com         
Share Market Highlights 26 February 2024 Sensex sheds 353 pts, Nifty closes at 22122 on profit takin...
Google News at Macroaxis
over a year ago at news.google.com         
Pharma stock jumps 4 percent after it won an order for supply of pharmaceuticals - Trade Brains
Google News at Macroaxis
over a year ago at news.google.com         
Kilitch Drugs India Ltds subsidiary wins tender from Ethiopia - Equity Bulls
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Kilitch Drugs that are available to investors today. That information is available publicly through Kilitch media outlets and privately through word of mouth or via Kilitch internal channels. However, regardless of the origin, that massive amount of Kilitch data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Kilitch Drugs news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Kilitch Drugs relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Kilitch Drugs' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Kilitch Drugs alpha.

Kilitch Drugs Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Kilitch Drugs Reports 106.4 percent Profit Growth in Q2 FY24-25 Amid Management Challenges - MarketsMojo
01/07/2025
2
Kilitch Drugs Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2024 - Marketscreener.com
02/12/2025

Complementary Tools for Kilitch Stock analysis

When running Kilitch Drugs' price analysis, check to measure Kilitch Drugs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kilitch Drugs is operating at the current time. Most of Kilitch Drugs' value examination focuses on studying past and present price action to predict the probability of Kilitch Drugs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kilitch Drugs' price. Additionally, you may evaluate how the addition of Kilitch Drugs to your portfolios can decrease your overall portfolio volatility.
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Share Portfolio
Track or share privately all of your investments from the convenience of any device